psoriatic arthritis Flashcards

1
Q

x

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

x

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

x

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

x

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

x

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

x

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Features of psoriatic arthritis

A

Symmetric polyarthritis
tenderness in the distal and
interphalangeal joints MCP
= better with work

“Dactylitis is the swelling of an entire digit

=======

asymmetrical oligoarthritis
affects hands and feet

========

3) sacroiliitis

4) DIP joint disease (10%)

5) arthritis mutilans (severe deformity fingers/hand, ‘telescoping fingers’)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Other signs of psoriatic arthritis ?

A

nail changes:
pitting
onycholysis

periarticular disease - tenosynovitis and soft tissue inflammation resulting in:
enthesitis: inflammation at the site of tendon and ligament insertion e.g. Achilles tendonitis, plantar fascitis
tenosynovitis: typically of the flexor tendons of the hands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

X-ray

A

coexistence of erosive changes and new bone formation
periostitis
‘pencil-in-cup’ appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

x

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

mild peripheral arthritis/mild axial disease may be treated with ‘just’

A

NSAID, rather than all patients being on disease-modifying therapy as with RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

moderate/severe disease

A

methotrexate is typically used as in RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

if resistant to NSAIDS AND METHOTREXATE

A

ciclosporin

systemic retinoids

biological agents: infliximab, etanercept and adalimumab

ustekinumab (IL-12 and IL-23 blocker) is showing promise in early trials

apremilast: phosphodiesterase type-4 (PDE4) inhibitor → suppression of pro-inflammatory mediator synthesis and promotion of anti-inflammatory mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

x

A

oral methotrexate is used first-line

ciclosporin

systemic retinoids

biological agents: infliximab, etanercept and adalimumab

ustekinumab (IL-12 and IL-23 blocker) is showing promise in early trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly